...
首页> 外文期刊>Vaccine >Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children.
【24h】

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children.

机译:脑膜炎球菌PorA外膜蛋白序列变异对幼儿和学童六价PorA外膜囊泡疫苗有效性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Though meningococcal conjugate vaccines are effective against serogroup C, there is currently no vaccine solution for serogroup B disease. PorA outer membrane protein (OMP) is a potential serogroup B vaccine candidate. A hexavalent PorA outer membrane vesicle (OMV) vaccine has been evaluated in phase I and II trials with promising results. However, considerable sequence variation occurs in the variable regions (VRs) encoding these serosubtypes. By using five wild type P1.19,15 variant strains we examined the serum bactericidal antibody (SBA) titres from sera collected from toddlers and school children pre- and post-vaccination. The numbers of subjects with SBA titres of <4, 4 and >=8 varied greatly between the different strains. This was also reflected when >=4-fold rises in SBA titres were examined. This finding in sera from toddlers and school children may have implications for PorA based vaccines.
机译:尽管脑膜炎球菌结合疫苗对C血清群有效,但目前尚无针对B血清疾病的疫苗溶液。 PorA外膜蛋白(OMP)是潜在的B血清群疫苗候选者。六价PorA外膜囊泡(OMV)疫苗已在I和II期试验中进行了评估,并获得了可喜的结果。但是,在编码这些血清亚型的可变区(VR)中会发生相当大的序列变异。通过使用五种野生型P1.19,15变异株,我们检查了从接种疫苗前后的幼儿和学龄儿童血清中获得的血清杀菌抗体(SBA)滴度。在不同菌株之间,SBA滴度<4、4和> = 8的受试者数量差异很大。当检查SBA滴度的升高≥4倍时,也反映出这一点。幼儿和学童血清中的这一发现可能对基于PorA的疫苗有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号